US SB1505 | 2019-2020 | 116th Congress
Status
Spectrum: Bipartisan Bill
Status: Introduced on May 16 2019 - 25% progression, died in committee
Action: 2019-05-16 - Read twice and referred to the Committee on Finance.
Pending: Senate Finance Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on May 16 2019 - 25% progression, died in committee
Action: 2019-05-16 - Read twice and referred to the Committee on Finance.
Pending: Senate Finance Committee
Text: Latest bill text (Introduced) [PDF]
Summary
Requires prescription drug plan sponsors to report any suspicious activities relating to fraud, waste, or abuse under the Medicare prescription drug benefit and any corrective actions taken.
Title
Medicare Prescription Drug Fraud Prevention Act of 2019
Sponsors
Sen. John Cornyn [R-TX] | Sen. Benjamin Cardin [D-MD] |
History
Date | Chamber | Action |
---|---|---|
2019-05-16 | Senate | Read twice and referred to the Committee on Finance. |
Same As/Similar To
SB3129 (Related) 2019-12-19 - Read twice and referred to the Committee on Finance.
SB2543 (Related) 2019-09-25 - Placed on Senate Legislative Calendar under General Orders. Calendar No. 225.
SB4199 (Related) 2020-07-02 - Read twice and referred to the Committee on Finance. (Sponsor introductory remarks on measure: CR S4228)
SB2543 (Related) 2019-09-25 - Placed on Senate Legislative Calendar under General Orders. Calendar No. 225.
SB4199 (Related) 2020-07-02 - Read twice and referred to the Committee on Finance. (Sponsor introductory remarks on measure: CR S4228)
Subjects
Fraud offenses and financial crimes
Government information and archives
Health
Health care costs and insurance
Medicare
Prescription drugs
Government information and archives
Health
Health care costs and insurance
Medicare
Prescription drugs
US Congress State Sources
Type | Source |
---|---|
Summary | https://www.congress.gov/bill/116th-congress/senate-bill/1505/all-info |
Text | https://www.congress.gov/116/bills/s1505/BILLS-116s1505is.pdf |